Delivery Order SPE2DP22D0002-SPE2DP22F3107
Award Date 8/31/22
Potential Completion Date 8/31/22
Potential Value $19M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $12.3 million firm fixed price delivery order contract to provide Influenza Virus Vaccines. Glaxosmithkline will perform the work as the prime contractor from their location in Research Triangle Park, North Carolina, between March 4, 2022 and August 31, 2022.</p>
- The Defense Logistics Agency Troop Support Medical awarded a $28,575 delivery order to Glaxosmithkline, LLC for influenza virus vaccinations. Glaxosmithkline will provide the vaccinations as the prime contractor, performing work in Research Triangle Park, North Carolina under the firm fixed price contract. The contract runs from March 22, 2021 through November 12, 2021 to support the Defense Logistics Agency's medical programs through the delivery of influenza virus vaccines. No subcontractors...
- The Defense Logistics Agency Troop Support Medical awarded a $217,170 delivery order to Glaxosmithkline, LLC for influenza virus vaccinations. Glaxosmithkline will deliver the requested vaccinations as the prime contractor, performing the work out of its Research Triangle Park, North Carolina facility. The firm fixed price contract runs from March 22, 2021 through November 12, 2021 to support the Defense Logistics Agency's medical programs. No set aside designation or subcontractors were...
- The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $463,000 firm fixed price delivery order contract to supply influenza virus vaccines. As the prime contractor, Glaxosmithkline will deliver the vaccines from its Research Triangle Park, North Carolina facility to support DLA Troop Support Medical's influenza virus vaccination program. The contract runs from March 22, 2021 through November 12, 2021. No set aside designation or subcontractors were indicated. DLA...
- The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $5,982.80 firm fixed price purchase order to supply influenza virus vaccinations. As the prime contractor, Glaxosmithkline will deliver the requested vaccinations from its location in Durham, North Carolina, with performance under the contract spanning from September 28 to October 10, 2023. No subcontractors or set aside designations were indicated. The contract supports the Defense Logistics Agency's mission to...
- Glaxosmithkline, LLC will provide influenza virus vaccines to the Defense Logistics Agency Troop Support Medical (DLA) under an $17.5 million firm fixed price delivery order contract. As the prime contractor, Glaxosmithkline will deliver vaccines from its Research Triangle Park, North Carolina facility to support DLA's medical supply needs. No subcontractors or set aside designations were specified. This delivery order was awarded under an existing DLA medical product supply vehicle and will...
- This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...
- Glaxosmithkline, LLC has been awarded a $58,770 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to provide FLUARIX influenza virus vaccines. Performance will occur at Glaxosmithkline's Durham, North Carolina facility through October 15, 2024. Glaxosmithkline holds several indefinite delivery contracts with federal agencies to supply seasonal influenza vaccines and other pharmaceutical products,...
- This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The firm fixed price delivery order, valued at $29,850, has an ultimate completion date of October 19, 2018. The contract was not set aside for any socioeconomic category. Glaxosmithkline, LLC has also received multiple award indefinite delivery vehicles from the Centers for Disease...
- This is a delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Glaxosmithkline, LLC, a pharmaceutical company, to provide flu vaccine for Fiscal Year 2019. The contract has a total potential value of $130,416.00 and is a firm fixed price agreement with no set-aside designation. The place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has multiple federal contracts and indefinite delivery vehicles to supply vaccines and...
- SPE2DP22D0002Indefinite Delivery Contract
- SPE2DP22D0002-SPE2DP22F3107Delivery Order
The Defense Logistics Agency Troop Support Medical awarded an $18.8 million firm fixed price delivery order contract to Glaxosmithkline, LLC for Influenza Virus Vaccines. The prime contractor Glaxosmithkline, LLC will perform the work at their facility located in Research Triangle Park, North Carolina. The period of performance is from August 31, 2022 through August 31, 2022. No applicable subcontractors were identified.
Generated 11/27/23, 7:27 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.8m | 3/4/22 |